Company Filing History:
Years Active: 2022-2024
Title: **The Innovative Contributions of Rainer Follador**
Introduction
Rainer Follador, an accomplished inventor based in Schlieren, Switzerland, has made significant strides in the field of immunology. With a total of three patents to his name, his work primarily focuses on the development of immunogenic compositions and vaccines, contributing to advancements in preventing and treating infectious diseases.
Latest Patents
Follador's latest patents include groundbreaking work on synthetic pneumococcal saccharides. His disclosures cover various formulations, such as the synthetic (e.g. recombinant) pneumococcal saccharides containing one or more repeat units: →4)-β-D-Glcp-(1→4)-[Gro-(2→P→3)]-β-D-Galp-(1→4)-β-L-Rhap-(1→. Additionally, he has developed conjugates that incorporate these saccharides, highlighting their potential use as immunogenic compositions and vaccines aimed at infection prevention and treatment.
Career Highlights
Follador's career has been marked by innovative contributions to the biotechnology sector. Currently employed at GlaxoSmithKline Biologicals SA, he plays a critical role in the company's research and development initiatives, focusing on immunotherapy and vaccine technology. His expertise has paved the way for novel approaches in tackling viral and bacterial infections.
Collaborations
Throughout his career, Follador has collaborated with esteemed colleagues, including Amirreza Faridmoayer and Stefan Jochen Kemmler. These partnerships have fostered a collaborative environment that enhances the creativity and innovation within their projects, ultimately leading to successful patent outcomes.
Conclusion
Rainer Follador exemplifies the spirit of innovation in the biotechnology field. His valuable contributions, particularly in the realm of immunogenic compositions and vaccines, underscore the importance of research and collaboration in advancing public health solutions. The path he has paved through his patents will undoubtedly inspire future inventors and researchers in the ongoing quest to combat infectious diseases.